![]() |
市場調查報告書
商品編碼
1885815
單細胞蛋白水解物市場機會、成長促進因素、產業趨勢分析及預測(2025-2034年)Single-Cell Protein Hydrolysates Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
||||||
2024 年全球單細胞蛋白水解物市值為 2.884 億美元,預計到 2034 年將以 9.5% 的複合年成長率成長至 7.21 億美元。

單細胞蛋白(SCP)水解物正成為永續蛋白質經濟的關鍵組成部分,這得益於其優異的消化率、豐富的氨基酸來源以及源自細菌、酵母、真菌和微藻等微生物的功能特性。 SCP的生產環境足跡小,通常利用廢棄物或氣基原料,使其在動物營養、人類食品和營養保健品領域極具吸引力。隨著全球蛋白質需求的成長和環境壓力的加劇,SCP水解物在水產養殖飼料、臨床營養和循環生物經濟策略中日益受到重視。 SCP水解物與循環系統的契合,特別是利用工業廢氣、有機殘渣和生質能衍生底物,有助於解決土地資源限制、減少排放和保障糧食安全等問題。這些因素正推動SCP水解物從新興技術走向廣泛應用的商業解決方案。
| 市場範圍 | |
|---|---|
| 起始年份 | 2024 |
| 預測年份 | 2025-2034 |
| 起始值 | 2.884億美元 |
| 預測值 | 7.21億美元 |
| 複合年成長率 | 9.5% |
2024年,細菌來源的單細胞蛋白水解物市佔率佔比達34%,預計到2034年將以8.9%的複合年成長率成長。由於生質能生成速度快、可擴展性強以及與氣基底物相容,細菌和酵母平台生產的水解物市場持續成長。它們被用於改善腸道功能,而酵母來源的水解物,特別是來自釀酒酵母屬的水解物,在寵物食品和風味增強劑領域也越來越常見。
動物營養領域在2024年佔據45.4%的市場佔有率,預計到2034年將以9.3%的複合年成長率成長。水產養殖業是成長的主要驅動力,這得益於單細胞蛋白(SCP)原料的穩定性和易消化性,為傳統的海洋蛋白提供了一種永續的替代方案。微生物蛋白供應商正在為不同物種量身定做解決方案,寵物食品行業的製造商正在添加酵母和細菌水解物以改善適口性和促進消化健康。畜牧業也在採用單細胞蛋白水解物來降低飼料成本並減少對傳統添加劑的依賴。
2024年美國單細胞蛋白水解物市場規模達7,030萬美元,預計2025年至2034年將以9.5%的複合年成長率成長。隨著許多創新者利用天然氣和工業副產品擴大單細胞蛋白水解物的生產,美國仍是飼料和營養應用領域規模化和技術進步的關鍵驅動力。
全球單細胞蛋白水解物市場的主要參與者包括Calysta、Unibio、Solar Foods、KnipBio、Quorn Foods、Arbiom、Corbion、DSM-Firmenich、Novozymes(現為Novonesis的一部分)、Angel Yeast、Lesaffre、Alltech、Nutreco和AlgaeCytes。這些企業正透過大規模發酵擴張、成本最佳化的生物加工以及先進的菌株工程來提升蛋白質產量和改善營養成分,從而鞏固其市場地位。許多公司正與飼料生產商和食品公司建立供應合作夥伴關係,以確保長期合約,同時根據特定物種的營養需求客製化水解物成分。永續發展承諾,包括使用廢棄物衍生原料和氣體驅動原料,正幫助企業脫穎而出,成為環保供應商。產品多元化、合規策略以及對臨床營養和功能性配方等高價值應用領域的投資,進一步鞏固了企業在全球市場的領先地位。
The Global Single-Cell Protein Hydrolysates Market was valued at USD 288.4 million in 2024 and is estimated to grow at a CAGR of 9.5% to reach USD 721 million by 2034.

Single-cell protein (SCP) hydrolysates are becoming a crucial component of the sustainable protein economy, supported by their strong digestibility, amino acid availability, and functional attributes derived from microbial sources such as bacteria, yeast, fungi, and microalgae. Their production is associated with a low environmental footprint, often relying on waste streams or gas-based feedstocks, which enhances their appeal across animal nutrition, human food applications, and nutraceuticals. As global protein requirements increase and environmental pressures intensify, SCP hydrolysates are gaining prominence in aquaculture diets, clinical nutrition, and circular bioeconomy strategies. Their alignment with circular systems, especially using industrial off-gases, organic residues, and biomass-derived substrates, helps address land constraints, emission reduction efforts, and food security priorities. These factors are moving SCP hydrolysates from emerging technologies into widely adopted commercial solutions.
| Market Scope | |
|---|---|
| Start Year | 2024 |
| Forecast Year | 2025-2034 |
| Start Value | $288.4 Million |
| Forecast Value | $721 Million |
| CAGR | 9.5% |
The bacterial SCP hydrolysates segment accounted for 34% in 2024 and is expected to grow at a CAGR of 8.9% by 2034. Hydrolysates produced from bacterial and yeast platforms continue to expand due to rapid biomass generation, strong scalability, and compatibility with gas-based substrates. They are used to enhance gut performance, while yeast-derived hydrolysates, particularly from Saccharomyces species, are becoming more common in pet food and flavor-enhancing applications.
The animal nutrition segment held a 45.4% share in 2024 and is projected to grow at a CAGR of 9.3% through 2034. Growth is led by aquaculture, driven by the stability and digestibility of SCP ingredients, offering a sustainable alternative to conventional marine-based proteins. Providers of microbial proteins are customizing solutions for various species, and manufacturers in the pet food sector are incorporating yeast and bacterial hydrolysates to improve palatability and digestive health. Livestock operations are also adopting SCP hydrolysates to lower feed expenses and reduce dependency on traditional additives.
U.S. Single-Cell Protein Hydrolysates Market reached USD 70.3 million in 2024 and is anticipated to register a CAGR of 9.5% from 2025 to 2034. With multiple innovators expanding SCP hydrolysate production using natural gas and industrial co-products, the United States remains a key driver of scale-up and technological advancement across feed and nutrition applications.
Major companies participating in the Global Single-Cell Protein Hydrolysates Market include Calysta, Unibio, Solar Foods, KnipBio, Quorn Foods, Arbiom, Corbion, DSM-Firmenich, Novozymes (now part of Novonesis), Angel Yeast, Lesaffre, Alltech, Nutreco, and AlgaeCytes. Companies competing in this market are strengthening their positions through large-scale fermentation expansion, cost-optimized bioprocessing, and advanced strain engineering to boost protein yields and enhance nutrient profiles. Many firms are forming supply partnerships with feed manufacturers and food companies to secure long-term contracts while tailoring hydrolysate compositions for species-specific nutritional needs. Sustainability commitments, including the use of waste-derived and gas-fed feedstocks, are helping companies stand out as environmentally aligned suppliers. Product diversification, regulatory compliance strategies, and investments in high-value applications such as clinical nutrition and functional formulations are further supporting stronger global market footholds.